As of 2025-09-16, the Relative Valuation of Appili Therapeutics Inc (APLI.TO) is (0.94) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 CAD, the upside of Appili Therapeutics Inc based on Relative Valuation is -6358.2%.
The range of the Relative Valuation is (1.22) - (0.59) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 37.3x - 42.3x | 39.8x |
| Forward P/E multiples | 17.3x - 18.2x | 17.8x |
| Fair Price | (1.22) - (0.59) | (0.94) |
| Upside | -8216.6% - -4053.9% | -6358.2% |
| Date | P/E |
| 2025-09-05 | -0.46 |
| 2025-09-04 | -0.46 |
| 2025-09-02 | -0.46 |
| 2025-08-26 | -0.61 |
| 2025-08-25 | -0.61 |
| 2025-08-22 | -0.61 |
| 2025-08-19 | -0.61 |
| 2025-08-18 | -0.61 |
| 2025-08-15 | -0.46 |
| 2025-08-13 | -0.46 |
| 2025-08-12 | -0.46 |
| 2025-08-11 | -0.46 |
| 2025-08-07 | -0.61 |
| 2025-08-06 | -0.46 |
| 2025-08-05 | -0.61 |
| 2025-08-01 | -0.61 |
| 2025-07-31 | -0.46 |
| 2025-07-29 | -0.46 |
| 2025-07-28 | -0.61 |
| 2025-07-24 | -0.46 |
| 2025-07-22 | -0.61 |
| 2025-07-21 | -0.46 |
| 2025-07-18 | -0.46 |
| 2025-07-17 | -0.46 |
| 2025-07-16 | -0.46 |
| 2025-07-11 | -0.46 |
| 2025-07-10 | -0.46 |
| 2025-07-09 | -0.46 |
| 2025-07-08 | -0.46 |
| 2025-07-07 | -0.46 |
| 2025-07-03 | -0.46 |
| 2025-07-02 | -0.46 |
| 2025-06-30 | -0.46 |
| 2025-06-27 | -0.46 |
| 2025-06-26 | -0.46 |
| 2025-06-25 | -0.46 |
| 2025-06-24 | -0.46 |
| 2025-06-23 | -0.31 |
| 2025-06-17 | -0.46 |
| 2025-06-16 | -0.46 |
| 2025-06-13 | -0.46 |
| 2025-06-12 | -0.46 |